A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, anemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myelodysplastic syndrome with excess blasts, myelodysplastic syndrome with single lineage dysplasia, myeloid leukemia, neoplasm	Recruiting	Phase 1	2026-01-16		NCT07347171

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cullgen (Shanghai),Inc	2

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital of Nanchang University	Nanchang	China	55
The Haematology Hospital of the Chinese Academy of Medical Sciences	Tianjin	China	1
Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	2